Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Cervical Cancer

Free Subscription Articles published in Int J Gynaecol Obstet Retrieve available abstracts of 104 articles: HTML format

Single Articles

April 2024
1. PATEL A, Suneja A, Malik R, Gupta B, et al
   Chromocolposcopy with fluorescein sodium for detection of premalignant and malignant lesions of the cervix: A cross-sectional study.
   Int J Gynaecol Obstet. 2024;165:169-175.
   PubMed     Abstract available
   
   
   March 2024
2. XU JY, Hu M, Wu SG, Zhou J, et al
   Local treatment strategies in Stage IVB cervical squamous cell carcinoma and adenocarcinoma.
   Int J Gynaecol Obstet. 2024;164:1053-1063.
   PubMed     Abstract available
   
   
   
3. STRATULAT V, Melamed N, Barrett J, Ladhani NNN, et al
   Cervical assessment certification and its impact on performance quality in the context of universal cervical screening.
   Int J Gynaecol Obstet. 2024;164:951-958.
   PubMed     Abstract available
   
   
   February 2024
4. MARINO-NOYA A, Magallanes-Pelaez N, Puga-Gonzalez N, Conde-Ferreiros M, et al
   Cervical carcinosarcoma, report of some cases and a literature review.
   Int J Gynaecol Obstet. 2024;164:795-796.
   PubMed    
   
   
   
5. JIA L, Wang L, Zheng J, Lu J, et al
   Ureter metastasis from a primary cervical malignancy 3 years after initial treatment.
   Int J Gynaecol Obstet. 2024;164:793-794.
   PubMed    
   
   
   January 2024
6. SABEENA S, Ravishankar N, Kalpana MM
   Implementation strategies of cervical cancer screening in South Asia: A systematic review.
   Int J Gynaecol Obstet. 2024 Jan 24. doi: 10.1002/ijgo.15366.
   PubMed     Abstract available
   
   
   
7. VAN DE SANDE AJM, Kengsakul M, Koeneman MM, Jozwiak M, et al
   The efficacy of topical imiquimod in high-grade cervical intraepithelial neoplasia: A systematic review and meta-analysis.
   Int J Gynaecol Obstet. 2024;164:66-74.
   PubMed     Abstract available
   
   
   December 2023
8. TANG X, Zhang X, Ding Y, Zhang Y, et al
   A long-term retrospective analysis of management of cervical cancer during pregnancy.
   Int J Gynaecol Obstet. 2023 Dec 27. doi: 10.1002/ijgo.15314.
   PubMed     Abstract available
   
   
   
9. DESRAVINES N, Hsu CH, Mohnot S, Sahasrabuddhe V, et al
   Feasibility of 5-fluorouracil and imiquimod for the topical treatment of cervical intraepithelial neoplasias (CIN) 2/3.
   Int J Gynaecol Obstet. 2023;163:862-867.
   PubMed     Abstract available
   
   
   November 2023
10. ZHANG Y, Wang C, Zhao Z, Cheng L, et al
    Survival outcomes of 2018 FIGO stage IIIC versus stages IIIA and IIIB in cervical cancer: A systematic review with meta-analysis.
    Int J Gynaecol Obstet. 2023 Nov 11. doi: 10.1002/ijgo.15218.
    PubMed     Abstract available
    
    
    
11. RAMESAN CK, Calvin JD, Thomas A, Fletcher J, et al
    Diagnostic study of human papillomavirus DNA detection in cervical and vaginal samples using the filter paper card.
    Int J Gynaecol Obstet. 2023;163:660-666.
    PubMed     Abstract available
    
    
    October 2023
12. VARGAS-CARDONA HD, Rodriguez-Lopez M, Arrivillaga M, Vergara-Sanchez C, et al
    Artificial intelligence for cervical cancer screening: Scoping review, 2009-2022.
    Int J Gynaecol Obstet. 2023 Oct 9. doi: 10.1002/ijgo.15179.
    PubMed     Abstract available
    
    
    
13. REIJNTJES B, Eising M, Kleppe M, Geuken E, et al
    The clinical relevance of excisional margins after large loop excision of the transformation zone for the persistence of cervical dysplasia.
    Int J Gynaecol Obstet. 2023;163:140-147.
    PubMed     Abstract available
    
    
    
14. HAMAR B, Teutsch B, Hoffmann E, Hegyi P, et al
    Trichomonas vaginalis infection is associated with increased risk of cervical carcinogenesis: A systematic review and meta-analysis of 470 000 patients.
    Int J Gynaecol Obstet. 2023;163:31-43.
    PubMed     Abstract available
    
    
    September 2023
15. LIU Y, He J, Liu P, Chen C, et al
    Postoperative management of FIGO 2018 stage IIA1 cervical squamous cell carcinoma with only one intermediate-risk factor: Is radiotherapy needed?
    Int J Gynaecol Obstet. 2023;162:1098-1105.
    PubMed     Abstract available
    
    
    
16. ZHOU Y, Wang C, Li W, Lu W, et al
    Fluorescence colposcope with TMTP1-PEG4-ICG is comparable to the conventional colposcope in identifying cervical precancerous lesions: A randomized controlled trial.
    Int J Gynaecol Obstet. 2023;162:969-976.
    PubMed     Abstract available
    
    
    July 2023
17. AMARAL E, Cain JM, Hearing F, Lumsden MA, et al
    FIGO guidance for sustainable implementation of vaccination programs for women: Pregnancy and HPV.
    Int J Gynaecol Obstet. 2023;162 Suppl 1:3-23.
    PubMed    
    
    
    June 2023
18. BONI SP, Horo A, Didi-Kouko-Coulibaly J, Tanon A, et al
    Impact of HIV infection on access to cancer care and survival among women with invasive cervical cancer in Cote d'Ivoire: A prospective cohort study.
    Int J Gynaecol Obstet. 2023 Jun 22. doi: 10.1002/ijgo.14925.
    PubMed     Abstract available
    
    
    
19. KASUGA Y, Hasegawa K, Hamuro A, Fukuma Y, et al
    Pregnancy outcomes following radical trachelectomy for early-stage cervical cancer: A retrospective observational study in the Kanto area, Japan.
    Int J Gynaecol Obstet. 2023 Jun 21. doi: 10.1002/ijgo.14935.
    PubMed     Abstract available
    
    
    
20. TOGAMI S, Tokudome A, Fukuda M, Mizuno M, et al
    Validation of single-photon emission computed tomography with computed tomography and lymphoscintigraphy for sentinel lymph node identification in cervical cancer.
    Int J Gynaecol Obstet. 2023 Jun 18. doi: 10.1002/ijgo.14917.
    PubMed     Abstract available
    
    
    May 2023
21. DE LA CRUZ-RAMIREZ YM, Olaza-Maguina AF
    Barriers to HPV vaccine uptake in adolescents of the indigenous Andean community of Peru.
    Int J Gynaecol Obstet. 2023 May 5. doi: 10.1002/ijgo.14844.
    PubMed    
    
    
    April 2023
22. GIANNELLA L, Delli Carpini G, Di Giuseppe J, Gardella B, et al
    Should attention be paid to the cone depth in the fully visible transformation zone? Retrospective analysis of 517 patients with cervical intraepithelial neoplasia grade 3.
    Int J Gynaecol Obstet. 2023;161:137-143.
    PubMed     Abstract available
    
    
    
23. TEHRANIAN A, Ghahghaei-Nezamabadi A, Seifollahi A, Mansouri P, et al
    Concurrent anorectal and cervical cytology in women with positive and negative cervical smear test results: A cross-sectional study.
    Int J Gynaecol Obstet. 2023;161:100-105.
    PubMed     Abstract available
    
    
    March 2023
24. YANG S, Zhao J, Zhao H, Hu Y, et al
    Development of a nomogram for predicting pelvic lymph node metastasis in cervical squamous cell carcinoma.
    Int J Gynaecol Obstet. 2023;160:1020-1027.
    PubMed     Abstract available
    
    
    February 2023
25. MCCLYMONT E, Money D
    The shift to one-dose HPV vaccination: Where does this leave women living with HIV?
    Int J Gynaecol Obstet. 2023 Feb 20. doi: 10.1002/ijgo.14713.
    PubMed    
    
    
    
26. DING T, Li L, Duan R, Chen Y, et al
    Risk factors analysis of recurrent disease after treatment with a loop electrosurgical excision procedure for high-grade cervical intraepithelial neoplasia.
    Int J Gynaecol Obstet. 2023;160:538-547.
    PubMed     Abstract available
    
    
    January 2023
27. XIAO SY, Major CK, O'Connell KA, Lee D, et al
    Breast and Cervical Cancer Screening Rates in Student-Run Free Clinics: A Systematic Review.
    Int J Gynaecol Obstet. 2023 Jan 16. doi: 10.1002/ijgo.14675.
    PubMed     Abstract available
    
    
    
28. MARQUES LS, Violin VGA, Meireles LEF, de Souza MVF, et al
    Kin17 high expression as a potential biomarker for high-grade cervical intraepithelial neoplasia.
    Int J Gynaecol Obstet. 2023;160:339-341.
    PubMed    
    
    
    December 2022
29. LEVIN G, Cohen L, Brandt B, Kogan L, et al
    Ethnical disparity in cervical cancer stage at diagnosis - a retrospective study in Israeli referral-center.
    Int J Gynaecol Obstet. 2022 Dec 24. doi: 10.1002/ijgo.14644.
    PubMed     Abstract available
    
    
    
30. MATSUO K, Violette CJ, Mandelbaum RS, Shoupe D, et al
    Utilizations and characteristics of ovarian conservation at hysterectomy for cervical carcinoma in-situ.
    Int J Gynaecol Obstet. 2022 Dec 1. doi: 10.1002/ijgo.14604.
    PubMed     Abstract available
    
    
    November 2022
31. BAO H, Zhao Y, Zhang X, Bi H, et al
    HPV-negative high-grade cervical precancerous lesions or invasive cancer in China: A post hoc analysis of a multicentric clinical study.
    Int J Gynaecol Obstet. 2022 Nov 29. doi: 10.1002/ijgo.14598.
    PubMed     Abstract available
    
    
    October 2022
32. REIS BS, Nogueira CM, Meneses AFP, Mellado BH, et al
    Experiences of women with advanced cervical cancer before starting the treatment: Systematic review of qualitative studies.
    Int J Gynaecol Obstet. 2022 Oct 2. doi: 10.1002/ijgo.14491.
    PubMed     Abstract available
    
    
    
33. SEOUD M, Jaafar I, Hamadeh R, Ammar W, et al
    Feasibility of Implementing Cytology Based Cervical Cancer Screening National Program in Lebanon: A pilot Study.
    Int J Gynaecol Obstet. 2022 Oct 2. doi: 10.1002/ijgo.14489.
    PubMed     Abstract available
    
    
    
34. JOHN JH, Halder A, Purwar S, Pushpalatha K, et al
    Study to determine efficacy of Urinary HPV 16 &18 detection in predicting premalignant and malignant lesions of Uterine Cervix.
    Int J Gynaecol Obstet. 2022 Oct 2. doi: 10.1002/ijgo.14486.
    PubMed     Abstract available
    
    
    September 2022
35. DE CARVALHO CF, da Costa LBE, de Moraes Sanches NCC, Damas II, et al
    Prognosis determination of Endocervical Adenocarcinomas morphologically reclassified in HPV associated or HPV Independent.
    Int J Gynaecol Obstet. 2022 Sep 8. doi: 10.1002/ijgo.14442.
    PubMed     Abstract available
    
    
    
36. MAILLIE L, Yussuph A, Chirangi B, Schroeder K, et al
    Outcomes From Eight Years of Cervical Cancer Screening at a Rural Screen-and-Treat Site in Northern Tanzania.
    Int J Gynaecol Obstet. 2022 Sep 2. doi: 10.1002/ijgo.14429.
    PubMed     Abstract available
    
    
    
37. VORA KS, Saiyed S, Joshi R, Natesan S, et al
    Prevalence of High Risk HPV amongst marginalized urban women in India and its implications on vaccination: A cross sectional study.
    Int J Gynaecol Obstet. 2022 Sep 1. doi: 10.1002/ijgo.14428.
    PubMed     Abstract available
    
    
    August 2022
38. DAU H, Trawin J, Nakisige C, Payne BA, et al
    The social and economic impacts of cervical cancer on women and children in low- and middle-income countries: a systematic review.
    Int J Gynaecol Obstet. 2022 Aug 13. doi: 10.1002/ijgo.14395.
    PubMed     Abstract available
    
    
    July 2022
39. HU SY, Zhao XL, Zhao FH, Wei LH, et al
    Implementation of Visual Inspection with Acetic Acid and Lugol's Iodine for Cervical Cancer Screening in Rural China.
    Int J Gynaecol Obstet. 2022 Jul 24. doi: 10.1002/ijgo.14368.
    PubMed     Abstract available
    
    
    June 2022
40. FRICK A, Azuaga A, Abdulcadir J
    Cervical dysplasia among migrant women with female genital mutilation/cutting type III: A cross-sectional study.
    Int J Gynaecol Obstet. 2022;157:557-563.
    PubMed     Abstract available
    
    
    April 2022
41. CIAVATTINI A, Di Giuseppe J, Marconi C, Giannella L, et al
    Hysterectomy for cervical intraepithelial neoplasia: A Retrospective observational multi-institutional study.
    Int J Gynaecol Obstet. 2022 Apr 27. doi: 10.1002/ijgo.14233.
    PubMed     Abstract available
    
    
    
42. THIANGPHAK E, Pruegsanusak K, Buhachat R
    Pretreatment lymphocyte count as independent prognostic factor in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy.
    Int J Gynaecol Obstet. 2022 Apr 23. doi: 10.1002/ijgo.14229.
    PubMed     Abstract available
    
    
    
43. GUO X, Tian S, Wang H, Zhang J, et al
    Outcomes associated with different surgical approaches to radical hysterectomy: A systematic review and network meta-analysis.
    Int J Gynaecol Obstet. 2022 Apr 4. doi: 10.1002/ijgo.14209.
    PubMed     Abstract available
    
    
    February 2022
44. TAWIAH A, Konney TO, Dassah ET, Visser LE, et al
    Determinants of Cervical Cancer Screening Uptake Among Women with Access to Free Screening: A Community-Based Study in Peri-Urban Ghana.
    Int J Gynaecol Obstet. 2022 Feb 25. doi: 10.1002/ijgo.14158.
    PubMed     Abstract available
    
    
    
45. ZHANG Y, Huang Y, Luo S, Li L, et al
    Therapeutic strategy analysis of patients with advanced stage high-grade neuroendocrine cervical cancer: A real-world multicenter study.
    Int J Gynaecol Obstet. 2022 Feb 5. doi: 10.1002/ijgo.14125.
    PubMed     Abstract available
    
    
    January 2022
46. SETIAWAN D, Miranti I, Partiwi TD, Puspitasari DA, et al
    The Willingness of Cervical Cancer Screening Among Sexually Active Women in Indonesia: Lesson Learned from 2 Districts.
    Int J Gynaecol Obstet. 2022 Jan 25. doi: 10.1002/ijgo.14113.
    PubMed     Abstract available
    
    
    
47. FU K, Lei M, Yang WQ, Wu LS, et al
    The treatment strategy of patients with positive margins after cervical cold knife conization-A 7-year retrospective study in China.
    Int J Gynaecol Obstet. 2022;156:159-165.
    PubMed     Abstract available
    
    
    December 2021
48. RAMIREZ M, de la Fuente J, Andia D, Hernandez JJ, et al
    "HPV vaccination coverage in women between 15-55 years in Spain. Temporal trend during the period 2007-2020".
    Int J Gynaecol Obstet. 2021 Dec 14. doi: 10.1002/ijgo.14067.
    PubMed    
    
    
    
49. AYDIN S, Karasu AFG, Marasli M, Bademler N, et al
    Reliability and diagnostic performance of smartphone colposcopy.
    Int J Gynaecol Obstet. 2021;155:404-410.
    PubMed     Abstract available
    
    
    November 2021
50. TU Y, Jiang P, Zhang J, Jiang S, et al
    The positive threshold of the immunohistochemical parameter Ki67 for predicting the recurrence of cervical cancer.
    Int J Gynaecol Obstet. 2021 Nov 4. doi: 10.1002/ijgo.14005.
    PubMed     Abstract available
    
    
    October 2021
51. BISPO PEREIRA EH, Camilo-Junior DJ, D'avilla SCGP, Mattar NJ, et al
    Comparison of Cervical Cancer Screening Results Among Public and Private Services in Brazil.
    Int J Gynaecol Obstet. 2021 Oct 16. doi: 10.1002/ijgo.13985.
    PubMed     Abstract available
    
    
    
52. OISHI T, Kigawa J, Iwanari O, Kasai T, et al
    Is cytology/HPV co-testing for cervical cancer screening useful in Japan?
    Int J Gynaecol Obstet. 2021 Oct 4. doi: 10.1002/ijgo.13961.
    PubMed     Abstract available
    
    
    
53. WILAILAK S, Kengsakul M, Kehoe S
    Worldwide initiatives to eliminate cervical cancer.
    Int J Gynaecol Obstet. 2021;155 Suppl 1:102-106.
    PubMed     Abstract available
    
    
    
54. WICHMANN IA, Cuello MA
    Obesity and gynecological cancers: A toxic relationship.
    Int J Gynaecol Obstet. 2021;155 Suppl 1:123-134.
    PubMed     Abstract available
    
    
    
55. BHATLA N, Aoki D, Sharma DN, Sankaranarayanan R, et al
    Cancer of the cervix uteri: 2021 update.
    Int J Gynaecol Obstet. 2021;155 Suppl 1:28-44.
    PubMed     Abstract available
    
    
    
56. RANDALL TC, Somashekhar SP, Chuang L, Ng JS, et al
    Reaching the women with the greatest needs: Two models for initiation and scale-up of gynecologic oncology fellowship trainings in low-resource settings.
    Int J Gynaecol Obstet. 2021;155 Suppl 1:115-122.
    PubMed     Abstract available
    
    
    
57. ADAMS TS, Rogers LJ, Cuello MA
    Cancer of the vagina: 2021 update.
    Int J Gynaecol Obstet. 2021;155 Suppl 1:19-27.
    PubMed     Abstract available
    
    
    September 2021
58. SANCHEZ-CUERDA C, Cuadra M, Gamir S, Lobo P, et al
    Cervical adenocarcinoma in situ during pregnancy and subsequent fertility-sparing therapy challenge.
    Int J Gynaecol Obstet. 2021 Sep 24. doi: 10.1002/ijgo.13948.
    PubMed     Abstract available
    
    
    
59. DICK A, Holyk T, Taylor D, Wenninger C, et al
    Highlighting strengths and resources that increase ownership of cervical cancer screening for Indigenous communities in Northern British Columbia: Community-driven approaches.
    Int J Gynaecol Obstet. 2021 Sep 8. doi: 10.1002/ijgo.13915.
    PubMed     Abstract available
    
    
    
60. NKWABONG E, Kengne B, Nkene Mawamba Y, Sando Z, et al
    Influence of the human immunodeficiency virus on cervical precancerous lesions.
    Int J Gynaecol Obstet. 2021;154:540-543.
    PubMed     Abstract available
    
    
    
61. JELINEK K, Harding L, Briceno R, Li Z, et al
    Prevalence of high-risk human papillomavirus genotypes in two regions of Peru.
    Int J Gynaecol Obstet. 2021;154:544-549.
    PubMed     Abstract available
    
    
    August 2021
62. ADCOCK A, Stevenson K, Cram F, MacDonald EJ, et al
    He Tapu Te Whare Tangata (sacred house of humanity): Under-screened Maori women talk about HPV self-testing cervical screening clinical pathways.
    Int J Gynaecol Obstet. 2021 Aug 11. doi: 10.1002/ijgo.13873.
    PubMed     Abstract available
    
    
    
63. CHO HW, Hong JH, Lee JK
    Detection of high-risk human papillomavirus infection and treatment of high-grade vaginal intraepithelial neoplasia: A single-institution study.
    Int J Gynaecol Obstet. 2021;154:227-232.
    PubMed     Abstract available
    
    
    July 2021
64. MUNGO C, Randa M, Shauri A, Serem D, et al
    Characteristics, stage at presentation, and status of women with cervical cancer at a major referral center in western Kenya.
    Int J Gynaecol Obstet. 2021 Jul 20. doi: 10.1002/ijgo.13831.
    PubMed     Abstract available
    
    
    
65. MWANAHAMUNTU M, Kapambwe S, Pinder LF, Matambo J, et al
    The use of thermal ablation in diverse cervical cancer 'screen-and-treat' service platforms in Zambia.
    Int J Gynaecol Obstet. 2021 Jul 1. doi: 10.1002/ijgo.13808.
    PubMed     Abstract available
    
    
    
66. MAHANDE MJ, Oneko O, Amour C, Pollie M, et al
    Feasibility and acceptability of human papillomavirus self-sampling in a semi-urban area in northern Tanzania.
    Int J Gynaecol Obstet. 2021;154:113-118.
    PubMed     Abstract available
    
    
    June 2021
67. YU Y, Deng T, Gu S
    Minimally invasive surgery and abdominal radical hysterectomy in patients with early-stage cervical cancer: A meta-analysis.
    Int J Gynaecol Obstet. 2021 Jun 24. doi: 10.1002/ijgo.13796.
    PubMed     Abstract available
    
    
    
68. TREJO MJ, Soliman AS, Chen Y, Kalima M, et al
    Effects of HIV infection on metastatic cervical cancer and age at diagnosis among patients in Lusaka, Zambia.
    Int J Gynaecol Obstet. 2021 Jun 14. doi: 10.1002/ijgo.13784.
    PubMed     Abstract available
    
    
    May 2021
69. TESKERECI G, Arslan UO, Oncel S
    The awareness levels of women on gynecological cancer in Turkey: A cross-sectional study.
    Int J Gynaecol Obstet. 2021 May 18. doi: 10.1002/ijgo.13745.
    PubMed     Abstract available
    
    
    
70. SOFTELAND S, Sebitloane MH, Taylor M, Roald BB, et al
    A systematic review of handheld tools in lieu of colposcopy for cervical neoplasia and female genital schistosomiasis.
    Int J Gynaecol Obstet. 2021;153:190-199.
    PubMed     Abstract available
    
    
    April 2021
71. DORJI T, Tshomo U, Gyamtsho S, Tamang ST, et al
    Gender-neutral HPV elimination, cervical cancer screening, and treatment: Experience from Bhutan.
    Int J Gynaecol Obstet. 2021 Apr 30. doi: 10.1002/ijgo.13728.
    PubMed     Abstract available
    
    
    March 2021
72. KEMPER KE, McGrath CJ, Eckert LO, Kinuthia J, et al
    Correlates of cervical cancer screening among women living with HIV in Kenya: A cross-sectional study.
    Int J Gynaecol Obstet. 2021 Mar 30. doi: 10.1002/ijgo.13690.
    PubMed     Abstract available
    
    
    
73. AGAROSSI A, Delli Carpini G, Sopracordevole F, Serri M, et al
    High-risk HPV positivity is a long-term risk factor for recurrence after cervical excision procedure in women living with HIV.
    Int J Gynaecol Obstet. 2021 Mar 15. doi: 10.1002/ijgo.13674.
    PubMed     Abstract available
    
    
    February 2021
74. TANG X, Qiu J, Guo C, Guo J, et al
    A novel prognostic nomogram utilizing the 2018 FIGO staging system for cervical cancer: A large multicenter study.
    Int J Gynaecol Obstet. 2021 Feb 15. doi: 10.1002/ijgo.13644.
    PubMed     Abstract available
    
    
    
75. MARINGA VD, Chikandiwa A, Gilham C, Mbodi L, et al
    Performance of the Swede score to predict cervical intraepithelial neoplasia in women with HIV-1 in Johannesburg, South Africa.
    Int J Gynaecol Obstet. 2021;152:188-195.
    PubMed     Abstract available
    
    
    January 2021
76. KRAMER J
    Eradicating cervical cancer: Lessons learned from Rwanda and Australia.
    Int J Gynaecol Obstet. 2021 Jan 17. doi: 10.1002/ijgo.13601.
    PubMed     Abstract available
    
    
    
77. TAMAUCHI S, Kajiyama H, Osuka S, Moriyama Y, et al
    Reduced response to controlled ovarian stimulation after radical trachelectomy: A pitfall of fertility-sparing surgery for cervical cancer.
    Int J Gynaecol Obstet. 2021 Jan 13. doi: 10.1002/ijgo.13529.
    PubMed     Abstract available
    
    
    
78. CHUNG MH, De Vuyst H, Greene SA, Topazian HM, et al
    Loop electrosurgical excision procedure (LEEP) plus top hat for HIV-infected women with endocervical intraepithelial neoplasia in Kenya.
    Int J Gynaecol Obstet. 2021;152:118-124.
    PubMed     Abstract available
    
    
    
79. LIU P, Dai E, Li W, He F, et al
    Effect of pre-operative radiotherapy on long-term outcomes among women with Stage IB1 to IIB cervical squamous cell carcinoma.
    Int J Gynaecol Obstet. 2021;152:125-132.
    PubMed     Abstract available
    
    
    
80. BUSS LF, Levi JE, Longatto-Filho A, Cohen DD, et al
    Attendance for diagnostic colposcopy among high-risk human papillomavirus positive women in a Brazilian feasibility study.
    Int J Gynaecol Obstet. 2021;152:72-77.
    PubMed     Abstract available
    
    
    
81. LI Y, Wang H, Zhang Y, Jing X, et al
    Correlation between multi-type human papillomavirus infections and viral loads and the cervical pathological grade.
    Int J Gynaecol Obstet. 2021;152:96-102.
    PubMed     Abstract available
    
    
    
82. YANG Y, Hu T, Ming X, Yang E, et al
    REBACIN(R) is an optional intervention for persistent high-risk human papillomavirus infection: A retrospective analysis of 364 patients.
    Int J Gynaecol Obstet. 2021;152:82-87.
    PubMed     Abstract available
    
    
    December 2020
83. KIM MH, Jung HJ, Park SI, Kim BJ, et al
    Self-obtained vaginal samples for HPV DNA testing to detect HPV-related cervical disease.
    Int J Gynaecol Obstet. 2020 Dec 23. doi: 10.1002/ijgo.13574.
    PubMed     Abstract available
    
    
    
84. TEIXEIRA JC, Santos DZ, Campos CS, Vale DB, et al
    Cervical cancer in women under 25 years of age and outside the screening age: Diagnosis profile and long-term outcomes.
    Int J Gynaecol Obstet. 2020 Dec 20. doi: 10.1002/ijgo.13553.
    PubMed     Abstract available
    
    
    
85. SIMELELA PN
    WHO global strategy to eliminate cervical cancer as a public health problem: An opportunity to make it a disease of the past.
    Int J Gynaecol Obstet. 2020 Dec 2. doi: 10.1002/ijgo.13484.
    PubMed    
    
    
    November 2020
86. BHATLA N, Nessa A, Oswal K, Vashist S, et al
    Program organization rather than choice of test determines success of cervical cancer screening: Case studies from Bangladesh and India.
    Int J Gynaecol Obstet. 2020 Nov 18. doi: 10.1002/ijgo.13486.
    PubMed     Abstract available
    
    
    
87. ROHNER E, Mulongo M, Pasipamire T, Oberlin AM, et al
    Mapping the cervical cancer screening cascade among women living with HIV in Johannesburg, South Africa.
    Int J Gynaecol Obstet. 2020 Nov 14. doi: 10.1002/ijgo.13485.
    PubMed     Abstract available
    
    
    
88. ALLENDE-PEREZ S, Dominguez-Ocadio G, Velez-Salas V, Isla D, et al
    Snapshot of symptoms of advanced cervical cancer patients referred to the palliative care service in a cancer center in Mexico.
    Int J Gynaecol Obstet. 2020 Nov 13. doi: 10.1002/ijgo.13479.
    PubMed     Abstract available
    
    
    
89. KUMAR S, Khanduri A, Sidibe A, Morgan C, et al
    Acting on the call: A framework for action for rapid acceleration of access to the HPV vaccination in low- and lower-middle-income countries.
    Int J Gynaecol Obstet. 2020 Nov 13. doi: 10.1002/ijgo.13482.
    PubMed     Abstract available
    
    
    
90. KENGSAKUL M, Laowahutanont P, Wilailak S
    Experiences in the prevention and screening of cervical cancer within Thailand.
    Int J Gynaecol Obstet. 2020 Nov 12. doi: 10.1002/ijgo.13481.
    PubMed     Abstract available
    
    
    
91. LINDEQUE G
    A perspective on cervical cancer prevention and screening in Africa.
    Int J Gynaecol Obstet. 2020 Nov 6. doi: 10.1002/ijgo.13476.
    PubMed     Abstract available
    
    
    
92. SHOU H, Yasuo Y, Yuan S, Lou H, et al
    Association of pretreatment SUVmax of cervix and SCC-antigen with FIGO2018 stage in Stage IIB-IVB squamous cervical cancer and relationship to prognosis.
    Int J Gynaecol Obstet. 2020 Nov 3. doi: 10.1002/ijgo.13465.
    PubMed     Abstract available
    
    
    
93. DANIEL GO, Musa J, Akindigh TM, Shinku F, et al
    Prevalence and predictors of precancerous cervical lesions among HIV-positive women in Jos, north-central Nigeria.
    Int J Gynaecol Obstet. 2020;151:253-259.
    PubMed     Abstract available
    
    
    October 2020
94. RAWAT A, Sanders C, Mithani N, Amuge C, et al
    Acceptability and preferences for self-collected screening for cervical cancer within health systems in rural Uganda: A mixed-methods approach.
    Int J Gynaecol Obstet. 2020 Oct 31. doi: 10.1002/ijgo.13454.
    PubMed     Abstract available
    
    
    
95. VALE DB, Teixeira JC, Braganca JF, Derchain S, et al
    Elimination of cervical cancer in low- and middle-income countries: Inequality of access and fragile healthcare systems.
    Int J Gynaecol Obstet. 2020 Oct 31. doi: 10.1002/ijgo.13458.
    PubMed     Abstract available
    
    
    
96. MAGDI R, Elshafeey F, Elshebiny M, Kamel M, et al
    A systematic review and meta-analysis of diagnostic accuracy of HPV tests for the screening of cervical cancer in low-resource settings.
    Int J Gynaecol Obstet. 2020 Oct 30. doi: 10.1002/ijgo.13455.
    PubMed     Abstract available
    
    
    
97. OKADOME M, Nagayama R, Shimokawa M, Sonoda K, et al
    Prognosis of bulky pT2b cervical cancer treated by radical hysterectomy comparing adenocarcinoma with squamous cell carcinoma using propensity score matching.
    Int J Gynaecol Obstet. 2020 Oct 29. doi: 10.1002/ijgo.13451.
    PubMed     Abstract available
    
    
    
98. LAWAL IK, Suleiman AK, Bagudu Z, Kanmodi KK, et al
    Planning and advocating for cervical cancer prevention in Kebbi State, Nigeria: Learning points for the global call to eliminate cervical cancer.
    Int J Gynaecol Obstet. 2020 Oct 8. doi: 10.1002/ijgo.13414.
    PubMed     Abstract available
    
    
    
99. YIM ET, Rogers TB, Msami K, Calixte R, et al
    Factors related to completion of referral among women with suspected cervical cancer and dysplasia in Tanzania.
    Int J Gynaecol Obstet. 2020 Oct 6. doi: 10.1002/ijgo.13412.
    PubMed     Abstract available
    
    
    September 2020
100. HOQUE MR, Haque E, Karim MR
     Cervical cancer in low-income countries: A Bangladeshi perspective.
     Int J Gynaecol Obstet. 2020 Sep 28. doi: 10.1002/ijgo.13400.
     PubMed     Abstract available
     
     
     July 2020
101. ORANG'O EO, Emont JP, Ermel AC, Liu T, et al
     Detection of types of HPV among HIV-infected and HIV-uninfected Kenyan women undergoing cryotherapy or loop electrosurgical excision procedure.
     Int J Gynaecol Obstet. 2020 Jul 26. doi: 10.1002/ijgo.13330.
     PubMed     Abstract available
     
     
     June 2020
102. RODRIGUEZ J, Fletcher A, Heredia F, Fernandez R, et al
     Alternative management for gynecological cancer care during the COVID-2019 pandemic: A Latin American survey.
     Int J Gynaecol Obstet. 2020 Jun 11. doi: 10.1002/ijgo.13272.
     PubMed     Abstract available
     
     
     April 2020
103. MCCLYMONT E, Lee M, Raboud J, Coutlee F, et al
     Prevalent and persistent oncogenic HPV types in a cohort of women living with HIV prior to HPV vaccination.
     Int J Gynaecol Obstet. 2020 Apr 27. doi: 10.1002/ijgo.13185.
     PubMed     Abstract available
     
     
     February 2020
104. TIMOTEO-LIAINA I, Khozaim K, Chen YA, Buenconsejo-Lum L, et al
     The rising relative and absolute incidence of uterine cancer in specific populations.
     Int J Gynaecol Obstet. 2020 Feb 29. doi: 10.1002/ijgo.13130.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.